Hospital Universiti Sains Malaysia

Kubang Kerian, Kelantan 16150

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma (HNSCC), Non Small Cell Lung Cancer, Type 2 Diabetes Mellitus

Studies at this site

• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus — Completed
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer — Completed